To assess the therapeutic potential of HDAC6 inhibition against endothelial cell injury during acute inflammation, we examined the effects of CAY10603 on caspase-3 activation in a mouse model of endotoxemia. The gene discussed is HDAC6; the disease is serum lipopolysaccharide activity.